Pharming (PHAR) Current Assets (2019 - 2026)

Pharming's Current Assets history runs 8 years deep, the most recent figure standing at $295.5 million for Q1 2026.

• Quarterly Current Assets rose 38.02% year-over-year to $295.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $295.5 million (up 38.02% YoY) and the FY2025 annual result came in at $299.5 million, up 7.55% from the prior year.
• Current Assets was $295.5 million for Q1 2026 at Pharming, down from $299.5 million in the prior quarter.
• Across five years, Current Assets topped out at $316.3 million in Q4 2023 and bottomed at $252048.0 in Q3 2022.
• A 5-year average of $258.7 million and a median of $277.6 million in 2025 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2022 — Current Assets tumbled 99.9% — and 2023, when it jumped 115646.6%.
• Pharming's Current Assets stood at $277.5 million in 2022, then increased by 14.0% to $316.3 million in 2023, then dropped by 11.98% to $278.4 million in 2024, then advanced by 7.55% to $299.5 million in 2025, then declined by 1.32% to $295.5 million in 2026.
• Business Quant data shows PHAR's Current Assets at $295.5 million in Q1 2026, $299.5 million in Q4 2025, and $277.6 million in Q3 2025.